G&E Healthcare Co (XKRX:299480) Debt-to-Equity : 0.00 (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Debt-to-Equity?

G&E Healthcare Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. G&E Healthcare Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. G&E Healthcare Co's Total Stockholders Equity for the quarter that ended in . 20 was ₩0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for G&E Healthcare Co's Debt-to-Equity or its related term are showing as below:

XKRX:299480's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.145
* Ranked among companies with meaningful Debt-to-Equity only.

G&E Healthcare Co Debt-to-Equity Historical Data

The historical data trend for G&E Healthcare Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Debt-to-Equity Chart

G&E Healthcare Co Annual Data

Trend

Debt-to-Equity

G&E Healthcare Co Semi-Annual Data

Debt-to-Equity

Competitive Comparison of G&E Healthcare Co's Debt-to-Equity

For the Biotechnology subindustry, G&E Healthcare Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G&E Healthcare Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Healthcare Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where G&E Healthcare Co's Debt-to-Equity falls into.

G&E Healthcare Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

G&E Healthcare Co's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

G&E Healthcare Co's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/
	=	N/A

G&E Healthcare Co (XKRX:299480) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

G&E Healthcare Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

G&E Healthcare Co (XKRX:299480) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955

Website

http://www.geherbs.com.tw

G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines